Ashish Mandelia
VP, Chief Accounting Officer · Mersana Therapeutics, Inc.
- 2024
- Oct 7, 2024
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ashish Mandelia files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mohan Bala - $762 in MRSN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ashish Mandelia?
Ashish Mandelia is a corporate insider, tracked as VP, Chief Accounting Officer of Mersana Therapeutics, Inc. (MRSN). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Ashish Mandelia last file a Form 4?
The only primary Form 4 on record is dated 7 October 2024.
Has Ashish Mandelia been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($16K) across all tracked filings.
